RNA interference (RNAi) is another way by which AEG-1 can be targeted, because this approach has shown efficacy in preclinical models and phase I clinical trials for other oncogenes in cancers such as HCC [245,246,247]. Here, MTDH is linked to hepatocellular carcinoma.